Research Experts Advance Non-Alcoholic Steatohepatitis Studies with Precision

  Everything Else

Cellomatics BioSciences introduces advanced in vitro models to accelerate drug discovery for Non-Alcoholic Steatohepatitis (NASH). The company’s specialized scientific team delivers precise, reliable assay systems that successfully replicate complex hepatic disease mechanisms. These consist of steatosis, inflammation, metabolic tension, and fibrosis. They provide not only accurate lipid quantification, promising biomarker data, and robust validation data to significantly empower global innovators in the ******ceutical and biotech sectors. The rigorous simulation of human disease progression provided by these models enhances early-stage efficacy testing of novel therapeutics. Partners trust Cellomatics to streamline workflows and expedite critical pipelines. Explore their comprehensive NASH research solutions by visiting their website today.


Phone: +44 (115) 865 4101

 Published date:

June 16, 2026

 Address:

Colwick, Nottingham NG4 2JY, United Kingdom

 Views

1



Share by email Share on Facebook Share on Twitter Share on Google+ Share on LinkedIn Pin on Pinterest

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

 User

Contact publisher